Attovia Therapeutics, Inc. Common Stock (ATTO) — Financial Flexibility Index
Attovia Therapeutics, Inc. Common Stock (ATTO) has a Financial Flexibility Index of -1.07x as of June 2026. Free cash flow of $-16.72 Million (operating CF $-16.79 Million minus capex $73.00K) represents -1% of total liabilities ($15.58 Million). Check Attovia Therapeutics, Inc. Common Stock (ATTO) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Attovia Therapeutics, Inc. Common Stock Financial Flexibility Index (2024–2025)
Historical Financial Flexibility Index trend for Attovia Therapeutics, Inc. Common Stock across 2 annual periods. For the full cash flow conversion analysis, see ATTO cash generation efficiency.
Annual Financial Flexibility Index for Attovia Therapeutics, Inc. Common Stock (2024–2025)
Year-by-year free cash flow to debt coverage for Attovia Therapeutics, Inc. Common Stock. Explore cash flow to debt ratio of Attovia Therapeutics, Inc. Common Stock to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.77x | $-56.89 Million | $-59.20 Million | $15.10 Million | ▼ -65.2% |
| 2024 | -2.28x | $-33.26 Million | $-35.03 Million | $14.59 Million | — |